Form 4: Generation Bio Co. Executive Antoinette Paone Reports Stock Transactions

Antoinette Paone, Chief Operating Officer of Generation Bio Co., reports the disposition of common stock and restricted stock units to cover tax obligations.

Summary

• On April 15, 2025, Antoinette Paone, the Chief Operating Officer of Generation Bio Co., engaged in transactions involving the company's stock.
• Paone disposed of 1,592 shares of common stock to satisfy tax withholding obligations related to the vesting of restricted stock units.
• Additionally, 468 shares were disposed of at a price of $0.3678 to cover tax liabilities.
• Following these transactions, Paone directly owns 23,082 shares of Generation Bio Co. common stock and 11,140 restricted stock units.
• The restricted stock units vest over four years, with the initial 25% vesting on January 15, 2024, and the remainder vesting in equal quarterly installments.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock transactions, common in publicly traded companies. It provides transparency into the trading activities of company insiders.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider trading activities.
• The vesting schedule of the restricted stock units (25% after one year, then quarterly) is a common vesting structure in the biotechnology industry.
• Companies like Amgen, Biogen, and Gilead Sciences also regularly file Form 4 documents for their executives.

Stakeholder Impact

• The transactions have a minimal direct impact on shareholders, as they relate to tax obligations of an executive.
• The filing provides transparency to stakeholders regarding insider transactions.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Transactions, Restricted Stock Units, Generation Bio Co., GBIO, Antoinette Paone, Executive Compensation